Physician profile
Meredith Heberer
NPI 1538484456
$7,637.84
in general payments reported to CMS, 2019-2025
13 companies · $38.16 in 2025
The $38.16 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $533 · 2020: $396 · 2021: $202 · 2022: $845 · 2023: $3,620 · 2024: $2,004 · 2025: $38.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Travel and Lodging: $2,017 · Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Travel and Lodging | $2,017.35 |
| Food and Beverage | $1,144.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,081.07 | 2019-2024 | Davinci Xi, Da Vinci Surgical System |
| Tela Bio, INC. | $2,011.13 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Covidien LP | $417.39 | 2019-2020 | |
| Davol INC. | $331.29 | 2022-2025 | Phasix Mesh |
| Acell, INC. | $223.34 | 2020 | |
| Medtronic, INC. | $214.39 | 2024 | Plasmablade(Tm), Aquamantys(Tm) |
| Avita Medical Americas, LLC | $130.83 | 2023 | Recell |
| Smith+Nephew, INC. | $130.50 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.89 | 2024 | Gattex |
| Goode Surgical INC | $20.56 | 2025 | |
| Dilon Technologies, INC. | $19.12 | 2024 | Hemoblast Bellows |
| Hologic Sales and Service, LLC | $15.98 | 2024 | Trunode, Localizer |
| Boston Scientific Corporation | $15.35 | 2024 | Spyglass Discover |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Heberer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.